Literature DB >> 21573340

Gestational trophoblastic disease - experience of the sheffield (United-kingdom) supraregional screening and treatment service.

E Sheridan1, B Hancock, S Smith, M Dorreen, F Neal, G Pennington, D Millar.   

Abstract

Abstract. The gestational trophoblastic diseases (GTD) are uncommon complications of pregnancy. The UK GTD registration scheme offers specialist facilities for screening and treatment. In Sheffield about 5% of all patients monitored require chemotherapy. The successful treatment - almost 100% cure - of these patients is a testament to the success of the registration scheme and undoubtedly this is one of the most cost efficient of all specialist medical treatments currently available.

Entities:  

Year:  1993        PMID: 21573340

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  2 in total

1.  Case report: Methotrexate-induced pericardial effusion.

Authors:  Betül Dündar; Alper Karalök; Işın Ureyen; Burcu Gündoğdu; Reyhan Oçalan; Taner Turan; Nurettin Boran; Gökhan Tulunay; M Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-03-01

2.  Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects.

Authors:  F Khan; J Everard; S Ahmed; R E Coleman; M Aitken; B W Hancock
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.